跳至主要内容
临床试验/DRKS00016920
DRKS00016920尚未招募不适用

Retrospective analysis of imaging modalities acquired during clinical diagnosis of patients with clinical suspected neurodegenerative Parkinsonian syndrome - MOPET

Klinik und Poliklinik für Nuklearmedizin, LMU München0 个研究点目标入组 50 人开始时间: 2019年3月18日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
40 Years 至 90 Years(—)
性别
All

入选标准

  • clinical suspected neurodegenerative Parkinsonian Syndrome and acquisition of at least one of the following modalities: cMRI, OCT, tau-PET

排除标准

  • other non-neurodegenerative CNS diseases like glioma or stroke

研究者

发起方
Klinik und Poliklinik für Nuklearmedizin, LMU München

相似试验

进行中(未招募)
1 期
Prospektive Evaluation von Multimodality Imaging Verfahren (PET - CT - MRT - US - Bildfusion) bei malignen Tumoren der Kopf-Hals-RegioPatients with malignant Head and Neck Tumors - Diagnostic Imaging StudyMedDRA version: 9.1Level: LLTClassification code 10049516Term: Malignant tumor
EUCTR2007-004393-81-ATMedizinische Universität Innsbruck - Universitätsklinik für Radiodiagnostik (Radiologie I)270
已完成
不适用
Analysis of Imaging Features From Patients Treated With Brolucizumab in the Post-marketing Setting With Reports of Retinal Vasculitis and/or Retinal Vascular OcclusionRetinal Vascular OcclusionIntraocular Inflammation
NCT05657158Novartis Pharmaceuticals198
尚未招募
1 期
The dislocation of Jaw Joint is assessed using special CT.
CTRI/2020/12/029529OGITHA SRI S
进行中(未招募)
1 期
Phase 2a open label study of Fovista¿ (anti-PDGF agent) administered in combination with anti-VEGF therapy in subjects previously treated or treatment-naive.Subfoveal choroidal neovascularization secondary to Age-Related Macular Degeneration (AMD)MedDRA version: 20.0Level: PTClassification code 10071129Term: Neovascular age-related macular degenerationSystem Organ Class: 10015919 - Eye disordersMedDRA version: 20.1Level: LLTClassification code 10067791Term: Wet macular degenerationSystem Organ Class: 10015919 - Eye disorders
EUCTR2015-000519-42-ITIVERIC bio, Inc.32
进行中(未招募)
1 期
Role of imaging in the evaluation of anatomic alterations in neovascular Age-Related Macular Degeneration (AMD) subjects: 18 month study of Fovista® (anti-PDGF therapy) administered in combination with anti-VEGF therapySubfoveal choroidal neovascularization secondary to Age-Related Macular Degeneration (AMD)MedDRA version: 18.0 Level: PT Classification code 10071129 Term: Neovascular age-related macular degeneration System Organ Class: 10015919 - Eye disordersMedDRA version: 18.0 Level: LLT Classification code 10067791 Term: Wet macular degeneration System Organ Class: 10015919 - Eye disorders
EUCTR2015-000519-42-FROPHTHOTECH CORPORATIO32